Growth strategy and ROE of 5% or higher under the Medium-Term Management Plan
First written in FY2019. 5 of 11 entries say "Restated". Latest entry: 2026-08-12.
No other company in this theme has enough history to compare yet.
- 2026-08-12RestatedEarnings presentation
「●Promotion of M&A」
The company restated its policy of promoting M&A as a growth strategy for the nursing-care business. - FY2026RestatedAnnual report
「In the medium-term management plan covering the 3 years from the fiscal year ending March 2026 through the fiscal year ending March 2028, announced by our group on 20 May 2025, our group has positioned “growth strategy” and “building the foundation for sustainable growth” as the central themes going forward. In addition to strengthening existing businesses, we are actively considering M&A, mainly in the nursing care business, and the development of new businesses, while working to strengthen our structure for future corporate growth. We are also focusing on the proactive recruitment of foreign personnel and waste reduction, among other initiatives, to advance the achievement of the medium-term management plan.」
The medium-term management plan for the fiscal years ending March 2026 through March 2028, the growth strategy, building the foundation for sustainable growth, M&A mainly in the nursing care business, new business development and the recruitment of foreign personnel have continued. - 2026-06-19AdvancedM&A and Subsidiary Changes
「We decided to acquire the shares because we believe that bringing the company into our group by having Sawayaka Club acquire all of its shares will enable us to share management resources and expertise and create strong synergies, including an increased share in Hokkaido.」
The nursing-care-focused M&A and growth strategy progressed to a specific share acquisition involving the sharing of management resources and expertise and expansion of market share in Hokkaido. - FY2026-H1RestatedAnnual report
「There were no material changes during the interim consolidated accounting period to the management policies, management strategies or other matters established by our group.」
The company states that there have been no material changes to its management policies or management strategies, including the medium-term management plan. - FY2025ReframedAnnual report
「In the medium-term management plan covering the 3 years from the fiscal year ending March 2026 through the fiscal year ending March 2028, announced by our group on 20 May 2025, our group has positioned “growth strategy” and “building the foundation for sustainable growth” as the central themes going forward. In addition to strengthening existing businesses, we are actively considering M&A, mainly in the nursing care business, and the development of new businesses, while working to strengthen our structure for future corporate growth. We are also focusing on the proactive recruitment of foreign personnel and waste reduction, among other initiatives, to advance the achievement of the medium-term management plan. As a financial target, we will work to secure ROE of at least 2.4% for the fiscal year ending March 2028.」
The period covered by the medium-term management plan was updated to the fiscal years ending March 2026 through March 2028, and “building the foundation for sustainable growth,” the recruitment of foreign personnel and waste reduction were newly specified. M&A mainly in the nursing care business and new business development have continued. - FY2025-H1RestatedAnnual report
「There were no material changes during the interim consolidated accounting period to the management policies, management strategies or other matters established by our group.」
The company states that there have been no material changes to its management policies or management strategies, including the medium-term management plan. - FY2024Updated the results for the second year of the medium-term management planAnnual report
「In the medium-term management plan covering the 3 years from the fiscal year ending March 2023 through the fiscal year ending March 2025, announced by our group on 19 May 2022, our group has positioned the “growth strategy” as the central theme going forward. In addition to strengthening existing businesses, we are actively considering M&A, mainly in the nursing care business, and the development of new businesses, while working to strengthen our structure for future corporate growth.」
The medium-term management plan for the fiscal years ending March 2023 through March 2025 and the policies for the growth strategy, M&A mainly in the nursing care business and new business development have continued. In the second year of the plan, results for the fiscal year ended March 2024 were revenue of ¥28,842.902 million, operating income of ¥589.051 million and ROE of 1.7%, below the fiscal year ending March 2025 plan of revenue of ¥31,749.762 million, operating income of ¥1,500.941 million and ROE of 6.6%. - FY2023RaisedAnnual report
「In the medium-term management plan covering the 3 years from the fiscal year ending March 2023 through the fiscal year ending March 2025, our group has positioned the “growth strategy” as the central theme going forward. In addition to strengthening existing businesses, we are actively considering M&A, mainly in the nursing care business, and the development of new businesses, while working to strengthen our structure for future corporate growth.」
The period covered by the medium-term management plan was updated to the fiscal years ending March 2023 through March 2025. The growth strategy, M&A mainly in the nursing care business and new business development have continued. The financial target was updated to ROE of at least 6.6% for the fiscal year ending March 2025. - FY2023-Q3RestatedAnnual report
「There were no material changes to the management policies, management strategies or other matters established by our Group during the cumulative third-quarter period.」
The Company states that there have been no material changes to its management policies and management strategies, including the medium-term management plan. - FY2020ReframedAnnual report
「In the medium-term management plan covering the 3 years from the fiscal year ending March 2020 through the fiscal year ending March 2022, our group has positioned the “growth strategy” as the central theme going forward. In addition to strengthening existing businesses, we are actively considering M&A, mainly in the nursing care business, and the development of new businesses, while working to strengthen our structure for future corporate growth.」
The medium-term management plan was changed from the fiscal years ending March 2017 through March 2019 to the fiscal years ending March 2020 through March 2022. Targets for the fiscal year ending March 2022 included revenue of ¥31,572.241 million, operating income of ¥1,909.982 million and ROE of at least 5.0%, while the earnings forecast for the fiscal year ending March 2021 was left undetermined. - FY2019First statedAnnual report
「In the medium-term management plan covering the 3 years from the fiscal year ended March 2017 through the fiscal year ending March 2019, our group has positioned the “growth strategy” as the central theme going forward. In addition to strengthening existing businesses, we are actively considering M&A, mainly in the nursing care business, and the development of new businesses, while working to strengthen our structure for future corporate growth. Alongside vigorous investment in new openings and M&A, we have set a financial target of ROE of at least 5% for the fiscal year ending March 2019.」
The medium-term management plan covering the fiscal years ending March 2017 through March 2019 centers on a growth strategy, with investment in M&A mainly in the nursing care business, new business development and new openings, and a target ROE of at least 5% for the fiscal year ending March 2019.